Company Search:
Advanced Search
Sponsored Links
Guangxi Liuzhou Pharmaceutical Co Ltd Company Snapshot
Guangxi Liuzhou Pharmaceutical Co Ltd operates within the Drugs, proprietaries, and sundries sector. In addition to historical fundamental analyses, the complete report available to purchase compares Guangxi Liuzhou Pharmaceutical Co Ltd with three other drug stores in Asia: Hokuyaku Takeyama Holdings, Inc of Japan (2017 sales of 228.71 billion Japanese Yen [US$2.14 billion] of which 70% was Pharmaceutical Business), Enseval Putera Megatrading Tbk PT of Indonesia (19.67 trillion Indonesian Rupiahs [US$1.43 billion] of which 43% was Pharmaceuticals), and Chuangmei Pharmaceutical Co Ltd which is based in Hong Kong (4.74 billion Hong Kong Dollars [US$603.20 million] ).

Sales Analysis. During the year ended December of 2017, sales at Guangxi Liuzhou Pharmaceutical Co Ltd were 9.45 billion Chinese Renmimbi (US$1.50 billion). This is an increase of 25.0% versus 2016, when the company's sales were 7.56 billion Chinese Renmimbi. This was the fifth consecutive year of sales increases at Guangxi Liuzhou Pharmaceutical Co Ltd (and since 2012, sales have increased a total of 166%). Sales of Retail saw an increase of 41.1% in 2017, from 615.06 million Chinese Renmimbi to 867.85 million Chinese Renmimbi. Not all segments of Guangxi Liuzhou Pharmaceutical Co Ltd experienced an increase in sales in 2017: sales of Others fell 59.3% to 1.37 million Chinese Renmimbi. (However, this segment's sales were only a very small portion of the company's overall sales).
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Guangxi Liuzhou Pharmaceutical Co Ltd
  Stock Performance Chart for Guangxi Liuzhou Pharmaceutical Co Ltd
  Stock Data: Recent Stock Performance:
  Current Price (4/13/2018): 53.08
(Figures in Chinese Renmimbi)
1 Week 1.2%   13 Weeks 11.3%  
4 Weeks 11.3%   52 Weeks -5.9%  
Guangxi Liuzhou Pharmaceutical Co Ltd Key Data:
  Ticker: 603368 Country: China
  Exchanges: SHG Major Industry: Health Care Equipment & Services
    Sub Industry: Drugs, Proprietaries, & Sundries
  2017 Sales 9,446,982,832
(Year Ending Jan 2018).
Employees: 2,575
  Currency: Chinese Renmimbi Market Cap: 9,822,584,471
  Fiscal Yr Ends: December Shares Outstanding: 185,052,458
  Share Type: A GU Closely Held Shares: 78,120,146
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.